title: Industry and regulatory experience of the glycosylation of monoclonal antibodies.
abstract: We surveyed 23 antibody-related marketing applications for glycoform analytical and functional information. Our database analysis shows a clear trend of increasing sophistication of analytical methods used to identify and quantify glycans. These have revealed a high degree of complexity and heterogeneity of glycans attached to antibody products. The nature of the complexity is influenced by product type and expression system, and may be associated with functional consequences in some but not all cases.
authors.affiliation: Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Erik K
authors.initials: EK
authors.lastname: Read
authors.forename: Jun T
authors.initials: JT
authors.lastname: Park
authors.forename: Kurt A
authors.initials: KA
authors.lastname: Brorson
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000737:chemistry* / Q000627:therapeutic use; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D030562:Databases, Protein; D017277:Drug Approval; D004345:Drug Industry / Q000592:standards*; D019075:Electrophoresis, Capillary / Q000379:methods; D006031:Glycosylation; D006801:Humans; D008004:Licensure; D013058:Mass Spectrometry / Q000379:methods; D009844:Oligosaccharides / Q000032:analysis / Q000737:chemistry / Q000592:standards; D011134:Polysaccharides / Q000032:analysis / Q000737:chemistry* / Q000592:standards; D011786:Quality Control; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D009844:Oligosaccharides; D011134:Polysaccharides